MYC and lung carcinoma: Taken collectively, oncogenomics combined with ChIP and EMSA as well as gene reporter assay and various computational methods revealed novel cell metabolism associated c-Myc regulated genes to broaden the perspective of molecularly targeted therapies for lung cancer.